These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6800869

  • 1. National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins.
    Albers JJ, Grundy SM, Cleary PA, Small DM, Lachin JM, Schoenfield LJ.
    Gastroenterology; 1982 Apr; 82(4):638-46. PubMed ID: 6800869
    [Abstract] [Full Text] [Related]

  • 2. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 3. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Feb 01; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 4. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA, Johnson O, Ericsson M, Tollin C.
    Acta Chir Scand; 1982 Feb 01; 148(8):675-8. PubMed ID: 6820598
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD.
    Am J Cardiol; 2005 Nov 01; 96(9):1266-72. PubMed ID: 16253595
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.
    Cheung MC, Albers JJ.
    J Clin Invest; 1977 Jul 01; 60(1):43-50. PubMed ID: 194921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase in serum total cholesterol and low-density lipoprotein cholesterol by high-dose chenodeoxycholic acid in patients with radiolucent gallstones significantly reversed during preventive low dose after gallstone dissolution.
    Pérez-Aguilar F, Bretó M, Alegre B, Berenguer J.
    Digestion; 1985 Jul 01; 31(4):225-33. PubMed ID: 4007294
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Jul 01; 33(12):1682-4. PubMed ID: 6686774
    [Abstract] [Full Text] [Related]

  • 20. Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.
    Bielmann P, Brun D, Gagné C, Morrjani S, Jéquier JC, Bertrand M, Lupien PJ.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 01; 20(6):259-64. PubMed ID: 6125482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.